Genetic testing company 23andMe’s bankruptcy has led to a new consumer privacy issue: what happens to the DNA of millions of ...

Pharmaceutical companies and precision medicine companies could also use the data to develop new drugs. It wouldn’t be the ...

On March 23, direct-to-consumer genetic testing company 23andMe announced it had filed for bankruptcy. The move came after ...

The direct-to-consumer DNA testing service 23andMe filed for bankruptcy earlier this month, putting millions of customers' ...

Genetic testing service 23andMe has filed for Chapter 11 bankruptcy protection to keep the company running while reorganizing ...

Positive azenosertib clinical data demonstrated clinically meaningful results in patients with Cyclin E1+ platinum-resistant ovarian cancer (PROC) Topline data from registration-intent DENALI Part 2 ...

The DNA testing and genetics company has declared bankruptcy. Your personal information could be part of the company’s sale.

Contract Pharmaceutical Manufacturing Market is expected to reach USD 450.07 Bn by 2032, exhibiting a CAGR of 9.9% from 2025 to 2032. Mr. Shah Coherent Market Insights Pvt. Ltd. +1 2524771362 email us ...

IAG Cargo's Constant Climate product recorded a 22% increase in tonnage in 2024 as the company continued to invest in air cargo pharmaceutical transport ...

Direct-to-consumer genetic testing services carry considerable privacy risks, as the bankruptcy filing of Cailfornia-based ...